Selected article for: "non significant difference and significant difference"
Author: Qiang Zeng; Yong-zhe Li; Gang Huang; Wei Wu; Sheng-yong Dong; Yang Xu
Title: Mortality of COVID-19 is Associated with Cellular Immune Function Compared to Immune Function in Chinese Han Population
  • Document date: 2020_3_10
    • ID: 1k64g7m3_27
    Snippet: The phenomenon of lymphocyte depletion (PLD) observed in severe or critical cases (ICU) in 100% (Table 3) . As the disease progressed and clinical status deteriorated, the levels of lymphocytes progressively decreased before death. Further analyzing 178 cases without glucocorticoid treatment, their lymphocyte subsets showed that CD4 and CD8 T lymphocytes have significant difference (p < 0.01) between mild (Non-ICU) and severe or critical (ICU) ca.....
    Document: The phenomenon of lymphocyte depletion (PLD) observed in severe or critical cases (ICU) in 100% (Table 3) . As the disease progressed and clinical status deteriorated, the levels of lymphocytes progressively decreased before death. Further analyzing 178 cases without glucocorticoid treatment, their lymphocyte subsets showed that CD4 and CD8 T lymphocytes have significant difference (p < 0.01) between mild (Non-ICU) and severe or critical (ICU) cases ( Table 3 ).

    Search related documents:
    Co phrase search for related documents
    • clinical status and disease progress: 1, 2, 3, 4, 5
    • clinical status and glucocorticoid treatment: 1, 2
    • clinical status and ICU case: 1
    • clinical status and lymphocyte depletion: 1
    • clinical status and lymphocyte level: 1, 2
    • clinical status and PLD lymphocyte depletion: 1
    • clinical status and PLD lymphocyte depletion phenomenon: 1
    • clinical status and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43
    • critical severe case and glucocorticoid treatment: 1
    • critical severe case and lymphocyte level: 1
    • critical severe case and significant difference: 1
    • death decrease and disease progress: 1
    • death decrease and significant difference: 1
    • disease progress and glucocorticoid treatment: 1
    • disease progress and lymphocyte level: 1
    • disease progress and significant difference: 1, 2, 3, 4, 5, 6, 7
    • glucocorticoid treatment and lymphocyte level: 1
    • glucocorticoid treatment and significant difference: 1, 2, 3, 4, 5
    • ICU case and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9